KOL | LAWRENCE S MORSEDepartment of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, USA. | Department of ... |
KOL Resume for LAWRENCE S MORSE
| Year | |
|---|---|
| 2021 | Department of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, USA. |
| 2020 | Department of Ophthalmology & Vision Science, Vitreoretinal Research Laboratory, School of Medicine, University of California Davis, Davis, California, United States of America |
| 2019 | Department of Ophthalmology and Vision Science, University of California, Davis, Sacramento, California, USA |
| 2018 | Department of Ophthalmology, UC Davis Eye Center, Sacramento, CA, USA |
| 2017 | UC Davis Eye Center, University of California, Davis, Sacramento |
| 2016 | UC Davis Eye Center, University of California–Davis, Sacramento, California |
| 2015 | Department of Ophthalmology, University of California, Davis, Sacramento, California. |
| 2014 | From the University of California–Davis, Sacramento, California, USA Department of Ophthalmology, University of California-Davis Medical Center, Sacramento, California |
| 2013 | Department of Ophthalmology & Vision Science, University of California Davis, Davis, California |
| 2012 | Department of Ophthalmology and Vision Science, University of California Davis Health System Eye Center, 4860 Y Street, Suite 2400 Sacramento, CA 95817, USA |
| 2011 | From the Department of Ophthalmology and Vision Science, University of California Davis Eye Center, Sacramento, California. University of California Davis Eye Center, Sacramento, CA, USA |
| 2010 | From the Department of Ophthalmology and Vision Science, Davis Medical Center, University of California, Sacramento, California |
| 2009 | Department of Ophthalmology & Vision Science, University of California–Davis, Sacramento (Drs Lim, Tanimoto, Eliason, Brandt, Morse, and Park, and Mr Lum) |
| 2008 | Department of Ophthalmology and Vision Science, University of California Davis Medical Center, Sacramento, California |
| 2007 | From the Department of Ophthalmology and Vision Science, University of California, Davis Medical Center. |
| 2006 | Department of Ophthalmology & Vision Science, University of California—Davis, Sacramento, California |
| 2005 | Department of Ophthalmology, University of California-Davis, Sacramento, CA, USA |
| 2004 | From the Department of Ophthalmology and Molecular and Cellular Biology, University of California, Davis, California |
| 2001 | Department of Ophthalmology, University of California-Davis (L.S.M.), Davis, California, USA *Wilford Hall Medical Center, Lackland AFB, Texas; †University of Texas San Antonio; ‡University of California San Diego; §University of California Davis. |
| 2000 | Department of Ophthalmology, University of California Davis, Davis, California, USA |
| 1999 | Department of Ophthalmology, University of California, Davis (A.V.G., J.B.R., L.S.M.), Sacramento, California, USA |
| 1998 | Department of Ophthalmology, University of California, Davis, Sacramento, California, USA |
| 1997 | Department of Ophthalmology, University of California, Davis, Sacramento, California |
| 1996 | Department of Ophthalmology, University of California, Davis, Sacramento, 95816, USA. |
| 1995 | Department of Ophthalmology, University of California, Davis, Davis, California 95616 |
| 1994 | Department of Ophthalmology, University of California, Davis, Sacramento. |
| 1992 | Retina Service, Department of Ophthalmology, University of California, Davis, Sacramento. |
| 1990 | The Retina Research Laboratory, Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles, CA, 90024, USA Retinal Service, Department of Ophthalmology, University of California, Davis Duke University Eye Center, Durham. |
| 1989 | The Retina Research Laboratory, Jules Stein Eye Institute, UCLA School of Medicine, 800 Westwood Plaza, Los Angeles, CA, 90024-1771, USA Retina Research Laboratory, Jules Stein Eye Institute, UCLA School of Medicine. |
LAWRENCE S MORSE: Influence Statistics
| Concept | World rank |
|---|---|
| micrornas circulatory micrornas | #1 |
| 1 developed cmvr | #1 |
| retinopathy mirnas | #1 |
| regression cytomegalovirus | #1 |
| cytometry cholesterol | #1 |
| injuries retinopathy | #1 |
| differential punctate staining | #1 |
| intraretinal environment | #1 |
| small noncoding forms | #1 |
| pupil dilation year | #1 |
| eyes 16 gye | #1 |
| gye arm | #1 |
| dopamine risk factor | #1 |
| rate stratus | #1 |
| pbt anti | #1 |
| immune recovery hypothesis | #1 |
| purpose layer humans | #1 |
| 2microm vesicles | #1 |
| ranibizumab combined | #1 |
| dme micropulse laser | #1 |
| circulatory mirnas | #1 |
| development threshold retinopathy | #1 |
| micropulse lasers | #1 |
| micrornas circulatory | #1 |
| gye 24 | #1 |
| rop dopamine | #1 |
| subthreshold 532 | #1 |
| radiation retinopathy proportion | #1 |
| cmv retinitis controversies | #1 |
| hrpe cells areas | #1 |
| tubules culture | #1 |
| premature infants dopamine | #1 |
| subsequent retinal detachments | #1 |
| brachytherapy humans armd | #1 |
| increase intracellular production | #1 |
| dme ranibizumab injections | #1 |
| laser subthreshold | #1 |
| intraocular laser probe | #1 |
| progressively lower correlation | #1 |
| cmv retinitis investigators | #1 |
| required fibronectin | #1 |
Open the FULL List in Excel | |
Prominent publications by LAWRENCE S MORSE
OBJECTIVE: This pilot study collected preliminary information on the effectiveness and safety of infrared (810-nm) diode laser macular grid photocoagulation in patients with nonexudative age-related macular degeneration (AMD). Results from this pilot study were used in designing a larger, multicenter, randomized clinical trial.
DESIGN: A multicenter, randomized, controlled, clinical trial.
PARTICIPANTS: A total of 229 eyes of 152 patients with AMD were enrolled in the pilot study. ...
| Known for Prophylactic Treatment | Laser Macular | Treated Eyes | Visual Acuity | Randomized Pilot |
Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States
[ PUBLICATION ]
Importance: Among adults with diabetes in the United States, severe forms of diabetic retinopathy (DR) are significantly associated with a greater vision-related functional burden.
Objective: To assess the functional burden of DR across severity levels in the United States.
Design, Setting, and Participants: This cross-sectional study was based on 1004 participants 40 years or older with diabetes and valid ocular and sociodemographic outcomes in the National Health and Nutrition ...
| Known for United States | Diabetic Retinopathy | Functional Burden | Severe Npdr | Adults Diabetes |
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials
[ PUBLICATION ]
PURPOSE: To evaluate the association of subretinal hyperreflective material (SHRM) with visual acuity (VA), geographic atrophy (GA), and scar in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
DESIGN: Prospective cohort study within a randomized clinical trial.
PARTICIPANTS: The 1185 CATT participants.
METHODS: Masked readers graded scar and GA on fundus photography and fluorescein angiography and graded SHRM on time-domain and spectral-domain (SD) optical ...
| Known for Eyes Shrm | Visual Acuity | Fluorescein Angiography | Hyperreflective Material | Degeneration Treatments |
High-resolution Fourier-Domain Optical Coherence Tomography and Microperimetric Findings After Macula-off Retinal Detachment Repair
[ PUBLICATION ]
OBJECTIVE: To evaluate the morphologic changes in the macula of subjects with repaired macula-off retinal detachment (RD) using high-resolution Fourier-domain optical coherence tomography (FD OCT) and to perform functional correlation in a subset of patients using microperimetry (MP-1).
DESIGN: Prospective observational case series.
PARTICIPANTS: Seventeen eyes from 17 subjects who had undergone anatomically successful repair for macula-off, rhegmatogenous RD at least 3 months earlier ...
| Known for Fd Oct | Retinal Detachment | Optical Coherence | Photoreceptor Disruption | Resolution Fourier |
Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
[ PUBLICATION ]
OBJECTIVE: To compare baseline characteristics, treatment frequency, visual acuity (VA), and morphologic outcomes of eyes with >50% of the lesion composed of blood (B50 group) versus all other eyes (Other group) enrolled in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
DESIGN: Prospective cohort study within a multicenter randomized clinical trial.
PARTICIPANTS: CATT patients with neovascular age-related macular degeneration (AMD).
METHODS: Treatment for ...
| Known for Macular Degeneration | 1 Year | Lesion Size | Treatments Trials | Visual Acuity |
Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial
[ PUBLICATION ]
PURPOSE: We studied the 3-year efficacy and safety results of a 4-year study evaluating fluocinolone acetonide (FA) intravitreal implants in eyes with persistent or recurrent diabetic macular edema (DME).
DESIGN: Prospective, evaluator-masked, controlled, multicenter clinical trial.
PARTICIPANTS: We included 196 eyes with refractory DME.
METHODS: Patients were randomized 2:1 to receive 0.59-mg FA implant (n = 127) or standard of care (SOC additional laser or observation; n = 69). The ...
| Known for Diabetic Macular | Fluocinolone Acetonide | Intravitreal Implant | 6 Months | 2 Years |
Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema
[ PUBLICATION ]
PURPOSE: To evaluate the efficacy of micropulse laser in the early treatment of diabetic macular edema (DME) and its associated burden of anti-vascular endothelial growth factor (VEGF) injections.
METHODS: This retrospective comparative study compared a group of 19 eyes with DME treated with micropulse laser to a matched control group of 19 eyes with DME treated with ranibizumab injections without micropulse laser. Recorded parameters included previous medical and ocular history, ...
| Known for Micropulse Laser | Diabetic Macular Edema | Intravitreal Injections | 12 Months | Visual Acuity |
OBJECTIVE: To characterize cytomegalovirus (CMV) retinitis in human immunodeficiency virus (HIV)-infected patients who demonstrate immune recovery while receiving highly active antiretroviral therapy (HAART).
DESIGN: Consecutive, noncomparative case series.
PARTICIPANTS: Twenty-two HIV-positive patients, from two institutions, with a history of CMV retinitis, and with elevated CD4 cell counts after HAART.
MAIN OUTCOME MEASURES: Duration of healed CMV retinitis without anti-CMV therapy, ...
| Known for Immune Recovery | Cytomegalovirus Retinitis | Aids Patients | Anticmv Therapy | Highly Active |
Effect of Diabetic Retinopathy and Panretinal Photocoagulation on Retinal Nerve Fiber Layer and Optic Nerve Appearance
[ PUBLICATION ]
OBJECTIVE: To determine if panretinal photocoagulation (PRP) alters retinal nerve fiber layer (RNFL) thickness and optic nerve appearance.
METHODS: Patients with diabetes who did and did not undergo PRP and nondiabetic control subjects were enrolled in a prospective study. Participants underwent optical coherence tomography of the peripapillary retina and optic nerve. Stereoscopic optic nerve photographs were graded in a masked fashion.
RESULTS: Ninety-four eyes of 48 healthy ...
| Known for Optic Nerve | Panretinal Photocoagulation | Diabetic Retinopathy | Fiber Layer | Eyes Prp |
Dopamine use is an indicator for the development of threshold retinopathy of prematurity
[ PUBLICATION ]
AIM: To assess whether treatment of premature infants with dopamine is a risk factor for development of retinopathy of prematurity (ROP).
METHODS: A retrospective case series analysis of two groups was utilised with a minimum follow up of 6 months. Clinical profiles and patient risk factors were identified along with an evaluation of ROP progression and an analysis of clinical outcome. All infants were seen in a single community neonatal intensive care unit (NICU). 41 consecutive high ...
| Known for Threshold Retinopathy | Infants Dopamine | Newborn Infant | Gestational Age | Prematurity Rop |
HIGH RESOLUTION FOURIER-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OF RETINAL ANGIOMATOUS PROLIFERATION
[ PUBLICATION ]
PURPOSE: To study the anatomic details of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration (AMD) using high-resolution Fourier-domain optical coherence tomography (Fd-OCT) and its three-dimensional reconstructions.
METHODS: A Fd-OCT instrument was used to image five patients clinically diagnosed with RAP. A series of 100 raster-scanned B-scans centered over the macula was registered and rendered as a three-dimensional volume. These retinal ...
| Known for Optical Coherence | Angiomatous Proliferation | Resolution Fourier | Rap Lesions | Fd Oct |
PURPOSE: Phase-variance optical coherence tomography (PV-OCT) provides volumetric imaging of the retinal vasculature without the need for intravenous injection of a fluorophore. We compare images from PV-OCT and fluorescein angiography (FA) for normal individuals and patients with age-related macular degeneration (AMD) and diabetic retinopathy.
DESIGN: This is an evaluation of a diagnostic technology.
PARTICIPANTS: Four patients underwent comparative retinovascular imaging using FA and ...
| Known for Variance Optical | Pv Oct | Coherence Tomography | Fluorescein Angiography | Retinal Vasculature |
Noninvasive Imaging of the Foveal Avascular Zone with High-Speed, Phase-Variance Optical Coherence Tomography
[ PUBLICATION ]
PURPOSE: To demonstrate the application of phase-variance optical coherence tomography (pvOCT) for contrast agent-free in vivo imaging of volumetric retinal microcirculation in the human foveal region and for extraction of foveal avascular zone dimensions.
METHODS: A custom-built, high-speed Fourier-domain OCT retinal imaging system was used to image retinas of two healthy subjects and eight diabetic patients. Through the acquisition of multiple B-scans for each scan location, phase ...
| Known for Foveal Avascular Zone | Coherence Tomography | Variance Optical | Diabetic Patients | Retinal Imaging |
The Prevalence of Myopic Choroidal Neovascularization in the United States Analysis of the IRIS® Data Registry and NHANES
[ PUBLICATION ]
PURPOSE: To determine the prevalence of high myopia (HM), progressive high (degenerative) myopia (PHM), and myopic choroidal neovascularization (mCNV) in the United States.
DESIGN: Cross-sectional study.
PARTICIPANTS: Individuals aged 18 years and older participating in the National Health and Nutrition Examination Survey (NHANES) and patients aged 18 years and older seen in clinics participating in the American Academy of Ophthalmology's Intelligent Research in Sight (IRIS(®)) ...
| Known for United States | Choroidal Neovascularization | Prevalence Myopia | Iris Registry | 18 Years |
Key People For Diabetic Retinopathy
LAWRENCE S MORSE:Expert Impact
Concepts for whichLAWRENCE S MORSEhas direct influence:Diabetic retinopathy, Aids patients, Micropulse laser, Visual acuity, Optical coherence, Subretinal fluid, Fibroblast growth, Cytomegalovirus retinitis.
LAWRENCE S MORSE:KOL impact
Concepts related to the work of other authors for whichfor which LAWRENCE S MORSE has influence:Optical coherence, Diabetic retinopathy, Macular degeneration, Visual acuity, Retinal detachment, Cytomegalovirus retinitis, Laser photocoagulation.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |